Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure
NCT00561483
Acute Heart Failure, Female Urogenital Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT Number: NCT00911703
The purpose of this study is to determine if certain findings (blood tests, symptom improvement, etc.) after acute heart failure treatment can identify a group of patients who are safe for early hospital discharge.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
University of Cincinnati, Cincinnati, Ohio, United States
A fundamental question faced by physicians treating acute decompensated heart failure (ADHF) is "When has treatment worked sufficiently for safe discharge, and who requires further treatment?" Patients with ADHF have a high incidence of morbidity and mortality. Current guidelines for emergency department (ED) and hospital disposition of patients with ADHF are based on limited empirical evidence. This creates clinical uncertainty regarding disposition leads to prolonged hospitalizations, higher costs and increased resource consumption. The specific aim of the study is to develop a prediction rule from readily available clinical data to help physicians identify ADHF patients eligible for safe and early discharge from the ED and hospital after treatment is initiated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The exclusion criteria are:
Time frame: Measured 5 days and 30 days after ED presentation
Vanderbilt University
Other
Treatment Endpoints in Acute Decompensated Heart Failure
Acronym: DECIDE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00561483
Acute Heart Failure, Female Urogenital Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT04886128
Acute Heart Failure, Cardiovascular Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT04363697
Acute Heart Failure, Cardiovascular Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT05613218
Acute Heart Failure, Hypoxemia
Copenhagen, Denmark
View Trial Details